vs
Acadia Healthcare Company, Inc.(ACHC)とオープンテキスト(OTEX)の財務データ比較。上の社名をクリックして会社を切り替えられます
オープンテキストの直近四半期売上が大きい($1.3B vs $829.0M、Acadia Healthcare Company, Inc.の約1.5倍)。オープンテキストの純利益率が高く(13.5% vs 0.5%、差は12.9%)。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い(7.5% vs 2.2%)。過去8四半期でAcadia Healthcare Company, Inc.の売上複合成長率が高い(2.0% vs -3.0%)
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
オープンテキストコーポレーションは世界的なソフトウェア企業で、情報管理ソフトウェアの開発・販売を主な事業としています。世界各国のさまざまな業種の顧客に製品やソリューションを提供し、企業の情報資産の効率的な管理、コンプライアンスの徹底、デジタルトランスフォーメーションの推進を支援しています。
ACHC vs OTEX — 直接比較
損益計算書 — Q1 FY2026 vs Q3 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $829.0M | $1.3B |
| 純利益 | $4.5M | $172.7M |
| 粗利率 | — | 73.1% |
| 営業利益率 | — | 15.7% |
| 純利益率 | 0.5% | 13.5% |
| 売上前年比 | 7.5% | 2.2% |
| 純利益前年比 | -50.8% | — |
| EPS(希薄化後) | $0.05 | $0.70 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | $1.3B | ||
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.3B | ||
| Q2 25 | $869.2M | $1.3B | ||
| Q1 25 | $770.5M | $1.3B | ||
| Q4 24 | $774.2M | $1.3B | ||
| Q3 24 | $815.6M | $1.3B | ||
| Q2 24 | $796.0M | $1.4B |
| Q1 26 | $4.5M | $172.7M | ||
| Q4 25 | $-1.2B | $168.1M | ||
| Q3 25 | $36.2M | $146.6M | ||
| Q2 25 | $30.1M | $28.8M | ||
| Q1 25 | $8.4M | $92.8M | ||
| Q4 24 | $32.6M | $229.9M | ||
| Q3 24 | $68.1M | $84.4M | ||
| Q2 24 | $78.5M | $248.2M |
| Q1 26 | — | 73.1% | ||
| Q4 25 | — | 74.0% | ||
| Q3 25 | — | 72.8% | ||
| Q2 25 | — | 72.3% | ||
| Q1 25 | — | 71.6% | ||
| Q4 24 | — | 73.3% | ||
| Q3 24 | — | 71.7% | ||
| Q2 24 | — | 72.5% |
| Q1 26 | — | 15.7% | ||
| Q4 25 | -142.4% | 22.0% | ||
| Q3 25 | 4.7% | 21.0% | ||
| Q2 25 | 5.8% | 13.9% | ||
| Q1 25 | 1.7% | 16.7% | ||
| Q4 24 | 4.9% | 22.2% | ||
| Q3 24 | 12.1% | 16.3% | ||
| Q2 24 | 13.4% | 14.2% |
| Q1 26 | 0.5% | 13.5% | ||
| Q4 25 | -143.3% | 12.7% | ||
| Q3 25 | 4.3% | 11.4% | ||
| Q2 25 | 3.5% | 2.2% | ||
| Q1 25 | 1.1% | 7.4% | ||
| Q4 24 | 4.2% | 17.2% | ||
| Q3 24 | 8.4% | 6.6% | ||
| Q2 24 | 9.9% | 18.2% |
| Q1 26 | $0.05 | $0.70 | ||
| Q4 25 | $-12.98 | $0.66 | ||
| Q3 25 | $0.40 | $0.58 | ||
| Q2 25 | $0.33 | $0.11 | ||
| Q1 25 | $0.09 | $0.35 | ||
| Q4 24 | $0.36 | $0.87 | ||
| Q3 24 | $0.74 | $0.32 | ||
| Q2 24 | $0.85 | $0.91 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $1.3B |
| 総負債低いほど良い | $2.5B | $6.2B |
| 株主資本純資産 | $2.0B | $4.0B |
| 総資産 | $5.5B | $13.3B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | 1.57× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | $1.3B | ||
| Q4 25 | $133.2M | $1.3B | ||
| Q3 25 | $118.7M | $1.1B | ||
| Q2 25 | $131.4M | $1.2B | ||
| Q1 25 | $91.2M | $1.3B | ||
| Q4 24 | $76.3M | $1.1B | ||
| Q3 24 | $82.1M | $1.0B | ||
| Q2 24 | $77.2M | $1.3B |
| Q1 26 | $2.5B | $6.2B | ||
| Q4 25 | $2.5B | $6.4B | ||
| Q3 25 | $2.3B | $6.4B | ||
| Q2 25 | $2.3B | $6.4B | ||
| Q1 25 | $2.2B | $6.4B | ||
| Q4 24 | $2.0B | $6.4B | ||
| Q3 24 | $1.9B | $6.4B | ||
| Q2 24 | $1.8B | $6.4B |
| Q1 26 | $2.0B | $4.0B | ||
| Q4 25 | $1.9B | $4.0B | ||
| Q3 25 | $3.1B | $4.0B | ||
| Q2 25 | $3.1B | $3.9B | ||
| Q1 25 | $3.0B | $4.1B | ||
| Q4 24 | $3.1B | $4.2B | ||
| Q3 24 | $3.0B | $4.1B | ||
| Q2 24 | $3.0B | $4.2B |
| Q1 26 | $5.5B | $13.3B | ||
| Q4 25 | $5.5B | $13.6B | ||
| Q3 25 | $6.4B | $13.5B | ||
| Q2 25 | $6.3B | $13.8B | ||
| Q1 25 | $6.1B | $13.8B | ||
| Q4 24 | $6.0B | $13.7B | ||
| Q3 24 | $5.9B | $13.8B | ||
| Q2 24 | $5.7B | $14.2B |
| Q1 26 | 1.29× | 1.57× | ||
| Q4 25 | 1.28× | 1.58× | ||
| Q3 25 | 0.74× | 1.61× | ||
| Q2 25 | 0.74× | 1.62× | ||
| Q1 25 | 0.72× | 1.55× | ||
| Q4 24 | 0.64× | 1.51× | ||
| Q3 24 | 0.62× | 1.55× | ||
| Q2 24 | 0.62× | 1.52× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | $354.6M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $305.0M |
| FCFマージンFCF / 売上 | — | 23.8% |
| 設備投資強度設備投資 / 売上 | — | 3.9% |
| キャッシュ転換率営業CF / 純利益 | 13.78× | 2.05× |
| 直近12ヶ月FCF直近4四半期 | — | $809.6M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | $354.6M | ||
| Q4 25 | $-86.3M | $318.7M | ||
| Q3 25 | $73.2M | $147.8M | ||
| Q2 25 | $133.5M | $158.2M | ||
| Q1 25 | $11.5M | $402.2M | ||
| Q4 24 | $116.7M | $348.0M | ||
| Q3 24 | $163.1M | $-77.8M | ||
| Q2 24 | $171.1M | $185.2M |
| Q1 26 | — | $305.0M | ||
| Q4 25 | $-179.5M | $279.4M | ||
| Q3 25 | $-63.0M | $101.2M | ||
| Q2 25 | $-34.2M | $124.0M | ||
| Q1 25 | $-163.2M | $373.8M | ||
| Q4 24 | $-86.8M | $306.7M | ||
| Q3 24 | $-27.1M | $-117.1M | ||
| Q2 24 | $16.9M | $145.2M |
| Q1 26 | — | 23.8% | ||
| Q4 25 | -21.8% | 21.1% | ||
| Q3 25 | -7.4% | 7.9% | ||
| Q2 25 | -3.9% | 9.5% | ||
| Q1 25 | -21.2% | 29.8% | ||
| Q4 24 | -11.2% | 23.0% | ||
| Q3 24 | -3.3% | -9.2% | ||
| Q2 24 | 2.1% | 10.7% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 11.3% | 3.0% | ||
| Q3 25 | 16.0% | 3.6% | ||
| Q2 25 | 19.3% | 2.6% | ||
| Q1 25 | 22.7% | 2.3% | ||
| Q4 24 | 26.3% | 3.1% | ||
| Q3 24 | 23.3% | 3.1% | ||
| Q2 24 | 19.4% | 2.9% |
| Q1 26 | 13.78× | 2.05× | ||
| Q4 25 | — | 1.90× | ||
| Q3 25 | 2.02× | 1.01× | ||
| Q2 25 | 4.43× | 5.49× | ||
| Q1 25 | 1.37× | 4.33× | ||
| Q4 24 | 3.58× | 1.51× | ||
| Q3 24 | 2.39× | -0.92× | ||
| Q2 24 | 2.18× | 0.75× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
OTEX
| Customer support | $564.8M | 44% |
| Cloud services and subscriptions | $492.9M | 38% |
| License | $145.1M | 11% |
| Professional service and other | $79.6M | 6% |